Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Thoracic 1Myeloid 1Head & Neck 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 117Colonic Neoplasms 30Rectal Neoplasms 27Neoplasms 20Neoplasm Metastasis 19Esophageal Neoplasms 10Pancreatic Neoplasms 9Cholangiocarcinoma 7Colorectal Cancer Metastatic 6Carcinoma, Non-Small-Cell Lung 6Lung Neoplasms 3Gastrointestinal Neoplasms 3Adenocarcinoma Of Esophagus 3Adenocarcinoma 3Stomach Neoplasms 2Prostatic Neoplasms 2Biliary Tract Neoplasms 2Thyroid Neoplasms 1Recurrence 1Pancreatic Adenocarcinoma 1Oesophago-gastric Cancer 1Neoplasms, Second Primary 1Kidney Neoplasms 1KRAS and NRAS Wild-type Colorectal Cancer 1Histiocytosis 1Gallbladder Neoplasms 1Exanthema 1Esophageal Squamous Cell Carcinoma 1Elderly Metastatic Colorectal Cancer Patients 1Dihydropyrimidine Dehydrogenase Deficiency 1

Interventions

Magnetic Resonance Spectroscopy 7Radiotherapy 6Radiosurgery 4pembrolizumab 3Specimen Handling 3Paclitaxel 3Fluorodeoxyglucose F18 3Carboplatin 3sargramostim 2cediranib 2Thiotepa 2Radiation 2Nivolumab 2Melphalan 2IFL protocol 2Granulocyte Colony-Stimulating Factor 2Genetic Testing 2Gemcitabine 2FAPI-46 2Busulfan 2130-nm albumin-bound paclitaxel 2tipifarnib 1sodium thiosulfate 1regorafenib 1paclitaxel-Angiopep-2 conjugate 1montelukast 1etoposide phosphate 1entrectinib 1entinostat 1clevudine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × Panitumumab × Gastrointestinal × Clear all
NCT05786924 2026-04-21

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Servier

Phase 1/2 Recruiting
554 enrolled
CNSGastrointestinalHead & NeckMyeloidThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Histiocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡